Dede Willis
Investing Profile
Sweet spot: $1.5M
Range: $100K–$5M
Ventac Partners thesis
Rancho Santa Fe Bio RSF Bio is a clinical stage cardiovascular therapeutics platform company based in San Diego, California. The company is developing Ataciguat: a small molecule drug developed to… Read More
Sector and stage focus
- Series B: BioTech
- Seed: BioTech
- Series A: BioTech
- general: Colorado / Utah
- Pre-seed: BioTech
Is Dede Willis a fit for your round?
Upload your pitch deck and see whether Dede Willis appears in your top 20 matches.
Find investors for your deck